When it comes to ADHD treatment, sometimes it’s best to embrace a multimodal approach—a combination of several tailored, complementary approaches that work together to reduce symptoms. For many people, this ideal combination can include counseling, behavioral therapy, parenting training, a healthy lifestyle, school accommodations, and medication. In terms of ADHD medication, there are two main types:
Calming wall colors, nature-themed murals, and soft nighttime lighting are all part of a unique new state-of-the-art inpatient psychiatric unit that focuses especially on children and adolescents who have experienced significant trauma. The 16-bed unit, which has been in the works for 3½ years and opened June 30 at the University of Maryland Medical Center
Subtle differences in brain morphometric features present in adolescence were associated with the subsequent development of psychosis in what is believed to be the largest neuroimaging investigation to date involving people at clinical high risk (CHR). Investigators found widespread lower cortical thickness (CT) in individuals at CHR, consistent with previously reported CT differences in individuals
New digital tools are on the horizon to help patients with attention-deficit/hyperactivity disorder (ADHD) manage the condition. Speakers at the World Congress on ADHD – Virtual Event described innovations aimed at improving medication compliance or reducing symptoms through the use of smartphone technology such as apps and text messaging, and video games. Some of these
MONDAY, Oct. 5, 2020 — There’s a link between attention-deficit hyperactivity disorder (ADHD), financial stress and suicide risk, a new study suggests. Researchers analyzed data on ADHD and suicide in Sweden from 2002 to 2015, as well as credit and default data from a random sample of more than 189,000 Swedish adults for the same
(HealthDay)—If the latest statistics are any indication, attention-deficit/hyperactivity disorder (ADHD) is no longer an issue for children only. Over a 10-year period, ADHD rates more than doubled among American adults, new research shows. However, the rate among children remains much higher than in adults. “While we can’t pinpoint the source of the increase in ADHD
Study links taking Tylenol in pregnancy to two-fold higher risks of having children with ADHD and autism – but experts say the household painkiller is an unlikely cause Researchers analyzed umbilical cord blood samples of acetaminophen, known by the brand name of Tylenol They then examined diagnoses of ADHD, autism or developmental disabilities Twice as many children
Attention-deficit hyperactivity disorder (ADHD) is a widespread condition with complex underlying causes. A stimulant drug called methylphenidate is a common ADHD treatment that impacts the brain’s levels of dopamine, a neurotransmitter involved in systems of reward; however, methylphenidate has a potential for abuse, and its therapeutic effects are poorly understood. To explore methylphenidate’s varied interactions
(HealthDay)—More U.S. children today have developmental disabilities like autism and ADHD than a decade ago, though improved recognition may be a major reason, according to a government study. Researchers found that between 2009 and 2017, the percentage of U.S. children and teens with a developmental disability rose from just over 16% to nearly 18%. Increases
Better training for teachers to understand ADHD and how to deal with it in the classroom is more important than targeted funding to support the student at school, ADHD experts say. Parents overwhelmingly believe teachers and key staff need professional development and training to better support children with attention deficit hyperactivity disorder (ADHD), according to
A comprehensive new review of the expanding scope of stimulants available to treat attention deficit hyperactivity disorder (ADHD) serves as a valuable guide to clinicians as they choose from among the many new drug formulations and technologies available to treat this complex disorder. The wide-ranging review is published in the Journal of Child and Adolescent
New research gives the clearest guidance yet on how schools can best support children with ADHD to improve symptoms and maximise their academic outcomes. The study, led by the University of Exeter and involving researchers at the EPPI-Centre (University College London), undertook a systematic review which analysed all available research into non-medication measures to support
There has been an increase in the use of medications to treat attention deficit hyperactivity disorder (ADHD) in both adults and children between 2001 and 2015, according to a major observational study involving over 154 million individuals from 14 countries in Europe, North America, Asia, and Australasia, published in The Lancet Psychiatry journal. The study
Stimulant medications are an effective treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). In the classroom, parents and teachers say that medications like methylphenidate (MPH) can reduce symptoms and improve behavior. Although stimulants have been in use for decades to treat ADHD in school-aged children, just how they work hasn’t been clear. But the results of a new
(HealthDay)—Exposure to hypertensive disorders of pregnancy (HDP) may be associated with an increase in the risk of autism spectrum disorder (ASD) and attention deficit/hyperactivity disorder (ADHD) in offspring, according to a review published online June 6 in JAMA Psychiatry. Gillian M. Maher, M.P.H., from University College Cork in Ireland, and colleagues conducted a systematic literature
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok